Skip to main content

Table 2 Component loadings

From: Application of principal component analysis and logistic regression model in lupus nephritis patients with clinical hypothyroidism

 

PC1

PC2

PC3

PC4

PC5

PC6

PC7

PC8

PC9

WBC

.020

−.023

.469

.094

−.006

.035

−.021

−.041

.084

HB

−.067

.206

.080

.018

−.024

−.097

.070

.179

.118

PLT

−.002

.105

.004

−.009

.129

−.237

−.075

.261

.054

N

.032

−.041

.471

.064

.009

.023

.007

−.109

.052

L

−.092

−.053

−.009

.017

−.017

.121

−.058

.405

.042

TP

.063

.366

−.022

.067

−.028

.128

−.017

−.008

−.015

ALB

.064

.405

−.058

−.077

−.122

.013

.007

−.048

.001

GLB

.031

.143

.026

.182

.083

.182

−.033

.037

−.023

Scr

.347

.092

−.029

−.108

.019

.039

−.009

−.079

−.137

BUN

.299

.055

.052

−.142

.033

.021

−.011

−.074

.069

UA

.311

.068

.084

.028

.028

.071

.027

.004

−.002

TG

.203

.060

.006

.138

−.109

−.015

.080

.068

−.005

TC

.159

.097

−.114

−.076

−.054

−.012

.030

.442

−.152

HDL

−.021

−.023

.057

−.315

.084

.178

.042

.185

−.152

LDL

.080

.135

.021

.000

−.140

−.273

.354

−.167

.245

HDLTC

−.147

−.021

.102

−.234

−.009

.225

.014

−.103

−.045

ESR

−.028

−.047

−.010

.128

.339

−.115

−.063

.119

−.036

CRP

.051

−.035

.056

−.104

.442

−.114

.114

−.242

−.157

C3

.060

.257

−.029

−.107

.063

−.141

−.008

.040

−.174

C4

−.035

−.021

−.011

.108

.060

−.429

−.027

−.118

.017

IgG

.057

.107

.012

.104

−.014

.289

−.052

−.010

−.019

IgA

−.021

−.099

−.013

−.186

.461

.020

.008

.025

.151

IgM

−.109

−.099

.130

.459

−.100

.080

.031

−.025

−.195

Anti-dsDNA antibodies

−.023

−.056

−.081

−.121

.138

.016

−.090

.163

.289

Anti-Sm antibodies

.035

.004

−.010

−.059

.004

.028

.488

−.039

−.078

Anti-SSA antibodies

.016

−.010

.001

−.060

−.018

.038

−.006

.088

.147

Anti-SSB antibodies

−.010

.013

−.037

−.018

−.051

−.053

.061

−.062

−.057

Anti-U1RNP antibodies

−.023

−.037

.000

−.021

.057

−.008

.444

−.027

−.045

Anti-RNP antibodies

−.020

.003

.093

−.057

−.035

−.036

.000

−.051

.579

  1. Loading pattern of the thirty clinical values on the nine main principal components. The loadings of the variables most relevant for the component interpretation are bolded